Home / Lifestyle / Ashley Graham on GLP-1s: 'A Smack in the Face'
Ashley Graham on GLP-1s: 'A Smack in the Face'
2 May
Summary
- Graham finds GLP-1 trend disheartening for body acceptance.
- She acknowledges GLP-1s are a current trend but won't erase plus-size women.
- Graham is accepting her postpartum body by focusing on motherhood.
Model Ashley Graham has voiced her concerns regarding the growing trend of GLP-1 medications like Ozempic and Wegovy. Speaking in a profile published on April 30, 2026, Graham described the trend as disheartening, suggesting it reverses progress made in body acceptance and positivity.
She articulated that the surge in popularity for these drugs feels like a rebuke to women who have advocated for self-love and acceptance. Graham acknowledged that GLP-1s represent a current cultural moment but emphasized that they will not eliminate the existence or visibility of plus-size women.
Graham is actively working on accepting her own postpartum body, sharing that her focus has shifted from achieving her previous physique to appreciating her role as a mother. She noted that embracing her current form has been a challenging, ongoing process over the past four years.
Looking ahead, Graham plans to continue fostering a community that champions body positivity. She highlighted the increasing number of plus-size influencers and creators who offer diverse representations, encouraging younger generations to embrace their authentic selves, regardless of perceived societal standards.
